| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | COLUCID PHARMACEUTICALS INC COM | 5,575 | 35,000 | 0.00% | ||
| 2 | CERES INC | 1,024,020 | 225,000 | 0.00% | ||
| 3 | ONCOCYTE CORP | 64,102 | 296,000 | 0.01% | ||
| 4 | PARNELL PHARMACEUT HLDGS LTD | 500,000 | 1,065,000 | 0.02% | ||
| 5 | REGENXBIO INC COM | 160,000 | 1,728,000 | 0.03% | ||
| 6 | Nantkwest Inc | 225,000 | 1,850,000 | 0.04% | ||
| 7 | AGENUS INC | 500,000 | 2,080,000 | 0.04% | Call | |
| 8 | GAMING & LEISURE PPTYS INC | 70,000 | 2,100,000 | 0.04% | ||
| 9 | DIMENSION THERAPEUTICS INC COM | 275,000 | 2,153,000 | 0.04% | ||
| 10 | CHEMOCENTRYX INC | 900,000 | 2,241,000 | 0.04% | ||
| 11 | IRONWOOD PHARMACEUTICALS INC COM CL A | 216,879 | 2,373,000 | 0.05% | ||
| 12 | CELLDEX THERAPEUTICS INC NEW | 675,000 | 2,552,000 | 0.05% | ||
| 13 | AGENUS INC | 750,000 | 3,120,000 | 0.06% | ||
| 14 | PALO ALTO NETWORKS | 20,000 | 3,263,000 | 0.06% | ||
| 15 | IGNYTA INC COM | 500,000 | 3,385,000 | 0.07% | ||
| 16 | BIOTIME INC | 1,282,050 | 3,679,000 | 0.07% | ||
| 17 | JUNO THERAPEUTICS INCORPORATED | 100,000 | 3,809,000 | 0.07% | Call | |
| 18 | SAREPTA THERAPEUTICS INC | 200,000 | 3,904,000 | 0.08% | Call | |
| 19 | AVEXIS INC COM | 175,000 | 4,767,000 | 0.09% | ||
| 20 | SPECTRANETICS CORP | 350,000 | 5,082,000 | 0.10% | ||
| 21 | CELLECTIS S A | 210,000 | 5,775,000 | 0.11% | ||
| 22 | SERES THERAPEUTICS INC | 225,000 | 5,976,000 | 0.12% | ||
| 23 | AGIOS PHARMACEUTICALS INC | 200,000 | 8,120,000 | 0.16% | Call | |
| 24 | LENDINGCLUB CORP | 1,125,000 | 9,338,000 | 0.18% | ||
| 25 | ALNYLAM PHARMACEUTICALS INC | 150,000 | 9,416,000 | 0.18% | Call | |
| 26 | DELTA AIRLINES INC DEL | 200,000 | 9,736,000 | 0.19% | ||
| 27 | JUNO THERAPEUTICS INCORPORATED | 265,000 | 10,094,000 | 0.20% | ||
| 28 | METLIFE INC | 235,000 | 10,326,000 | 0.20% | ||
| 29 | CITIGROUP INC | 250,000 | 10,438,000 | 0.20% | ||
| 30 | REGENERON PHARMACEUTICALS | 30,000 | 10,813,000 | 0.21% | Call | |
| 31 | ARRAY BIOPHARMA INC COM | 3,710,000 | 10,945,000 | 0.21% | ||
| 32 | JPMORGAN CHASE & CO | 200,000 | 11,844,000 | 0.23% | ||
| 33 | MORGAN STANLEY | 500,000 | 12,505,000 | 0.24% | ||
| 34 | BANK AMER CORP | 1,000,000 | 13,520,000 | 0.26% | ||
| 35 | AGIOS PHARMACEUTICALS INC | 335,000 | 13,601,000 | 0.27% | ||
| 36 | IONIS PHARMACEUTICALS INC | 350,000 | 14,175,000 | 0.28% | ||
| 37 | JPMORGAN CHASE & CO | 250,000 | 14,805,000 | 0.29% | Call | |
| 38 | MASTERCARD INCORPORATED | 200,000 | 18,900,000 | 0.37% | ||
| 39 | DELPHI AUTOMOTIVE PLC | 275,000 | 20,631,000 | 0.40% | ||
| 40 | CITIGROUP INC | 500,000 | 20,875,000 | 0.41% | Call | |
| 41 | BLUEBIRD BIO INCORPORATED | 500,000 | 21,250,000 | 0.41% | ||
| 42 | KITE PHARMA INCORPORATED | 485,000 | 22,266,000 | 0.43% | ||
| 43 | TEVA PHARMACEUTICAL INDS LTD | 450,000 | 24,080,000 | 0.47% | Call | |
| 44 | NEKTAR THERAPEUTICS COM | 2,000,000 | 27,500,000 | 0.54% | ||
| 45 | ALIBABA GROUP HLDG LTD | 375,000 | 29,636,000 | 0.58% | ||
| 46 | CELGENE CORP | 300,000 | 30,027,000 | 0.59% | Call | |
| 47 | GOLDMAN SACHS GROUP INC | 200,000 | 31,396,000 | 0.61% | ||
| 48 | METLIFE INC | 750,000 | 32,955,000 | 0.64% | Call | |
| 49 | BIOMARIN | 400,000 | 32,992,000 | 0.64% | ||
| 50 | WAL-MART STORES INC | 500,000 | 34,245,000 | 0.67% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-16-064880, filed 2016.05.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
